(STLG) iShares Factors US Growth - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E4035
STLG: Large, Growth, Stocks, Derivatives, Cash
The iShares Factors US Growth Style ETF (BATS:STLG) is an exchange-traded fund that tracks a specific index, focusing on US growth stocks. It is designed to provide investors with exposure to a particular segment of the market. The funds investment strategy is centered around replicating the performance of its underlying index, which is likely composed of growth-oriented equities.
The funds asset allocation is heavily weighted towards its underlying indexs component securities, with a minimum of 80% of its assets dedicated to these holdings. The remaining 20% can be invested in various financial instruments such as futures, options, and swap contracts, as well as cash and cash equivalents, allowing for flexibility in managing the portfolio. As a non-diversified fund, STLG may exhibit a higher level of concentration in its holdings compared to diversified funds.
From a technical standpoint, the funds price action indicates a potential bullish trend. The current price of $53.55 is above both the 20-day and 50-day simple moving averages (SMA20: $50.77, SMA50: $51.41), suggesting a short-term uptrend. However, the price is slightly below the 200-day simple moving average (SMA200: $53.70), indicating that the long-term trend is still uncertain. The average true range (ATR: 1.81) represents a 3.37% daily price fluctuation, signifying moderate volatility.
Given the current technical and fundamental data, a forecast for STLG can be constructed. With the 52-week high and low being $59.23 and $45.13, respectively, the fund is currently trading near the middle of its recent range. Considering the AUM of $352.17M USD, the fund has a reasonable size to maintain liquidity. If the underlying index continues to perform well, and the growth-oriented equities within the index maintain their momentum, STLG is likely to follow suit. A potential target price could be near the 52-week high of $59.23, representing a 10.5% increase from the current price. However, if the market experiences a downturn, the funds price could retrace to the SMA200 or even lower, at $51.41 or $50.77, respectively.
Additional Sources for STLG ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
STLG ETF Overview
Market Cap in USD | 483m |
Category | Large Growth |
TER | 0.25% |
IPO / Inception | 2020-01-14 |
STLG ETF Ratings
Growth Rating | 73.0 |
Fundamental | - |
Dividend Rating | 5.30 |
Rel. Strength | 1.86 |
Analysts | - |
Fair Price Momentum | 56.87 USD |
Fair Price DCF | - |
STLG Dividends
Dividend Yield 12m | 0.23% |
Yield on Cost 5y | 0.54% |
Annual Growth 5y | -12.44% |
Payout Consistency | 86.9% |
Payout Ratio | % |
STLG Growth Ratios
Growth Correlation 3m | 70.7% |
Growth Correlation 12m | 38.8% |
Growth Correlation 5y | 78.1% |
CAGR 5y | 19.23% |
CAGR/Max DD 5y | 0.62 |
Sharpe Ratio 12m | 1.51 |
Alpha | 3.69 |
Beta | 1.340 |
Volatility | 16.22% |
Current Volume | 49.9k |
Average Volume 20d | 52.6k |
As of June 15, 2025, the stock is trading at USD 58.63 with a total of 49,885 shares traded.
Over the past week, the price has changed by +0.86%, over one month by +2.64%, over three months by +15.64% and over the past year by +14.84%.
Yes. Based on ValueRay´s Analyses, iShares Factors US Growth (BATS:STLG) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 73.00 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of STLG is around 56.87 USD . This means that STLG is currently overvalued and has a potential downside of -3%.
iShares Factors US Growth has no consensus analysts rating.
According to our own proprietary Forecast Model, STLG iShares Factors US Growth will be worth about 66.4 in June 2026. The stock is currently trading at 58.63. This means that the stock has a potential upside of +13.3%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 66.4 | 13.3% |